The investigation of the relationship between polycystic ovary syndrome with metabolic changes in women
Archives of Medical Laboratory Sciences,
Vol. 5 No. 3 (2019),
1 July 2019
,
Page 1-5
https://doi.org/10.22037/amls.v5i3.29189
Abstract
Background: For exploring the relationship between metabolic changes and thyroid function in polycystic ovary syndrome (PCOS) patients, metabolic, endocrine, and thyroid parameters were assessed.
Materials and Methods: alterations in endocrine, metabolic, and clinical characteristics in PCOS patients compared with healthy women were studied within a prospective investigation. Also thyroid parameters were considered.
Results: 300 women with normal ovulatory as controls and PCOS patients were included and matched by age. There were significant increases in triglyceride (TG), cholesterol (CHL), and total dihydrotestosterone (DHT) in PCOS patients. Also, overall levels of Fast Blood Sugar (FBS), Follicle-stimulating hormone (FSH), Testosterone (T), Prolactin, and thyroid-stimulating hormone (TSH) were higher in compared with the normal women, but these higher amounts were not significant. There was an insignificant decrease in Luteinizing hormone(LH), high-density lipoprotein (HDL), and Free T4 in PCOS patients compared with the controls.
Conclusions: Our manuscript suggests the negative metabolic alterations in PCOS patients.The small increases of TG, CHL, and DHT levels may depend on these alterations in metabolic parameters in PCOS patients. Further investigations may clear a vague understanding of the relationship between metabolic parameters alteration and thyroid function.
- polycystic ovary syndrome (PCOS)
- metabolic changes
- T4
- triglyceride
- cholesterol.
How to Cite
References
Makedos A, Goulis D, Arvanitidou M, Mintziori G, Papanikolaou A, Makedou A, et al. Increased serum C-reactive protein levels in normal weight women with polycystic ovary syndrome. Hippokratia. 2011;15(4):323.
Siriwardene SD, Karunathilaka LA, Kodituwakku N, Karunarathne Y. Clinical efficacy of Ayurveda treatment regimen on Subfertility with poly cystic ovarian syndrome (PCOS). Ayu. 2010;31(1):24.
Tehrani FR, Simbar M, Tohidi M, Hosseinpanah F, Azizi F. The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reproductive Biology and Endocrinology. 2011;9(1):39.
Gaberšcek S, Zaletel K, Schwetz V, Pieber T, Obermayer-Pietsch B, Lerchbaum E. Thyroid and polycystic ovary syndrome. Endocrinology. 2015;172:R9-R21.
Singla R, Gupta Y, Khemani M, Aggarwal S. Thyroid disorders and polycystic ovary syndrome: An emerging relationship. Indian journal of endocrinology and metabolism. 2015;19(1):25.
Calvar CE, Bengolea SV, Deutsch SI, Hermes R, Ramos G, Loyato M. High frequency of thyroid abnormalities in polycystic ovary syndrome. Medicina. 2015;75(4):213-7.
Trummer C, Schwetz V, Giuliani A, Obermayer-Pietsch B, Lerchbaum E. Impact of elevated thyroid-stimulating hormone levels in polycystic ovary syndrome. Gynecological Endocrinology. 2015;31(10):819-23.
Al-Saab R, Haddad S. Detection of thyroid autoimmunity markers in euthyroid women with polycystic ovary syndrome: a case-control study from Syria. International journal of endocrinology and metabolism. 2014;12(3).
Enzevaei A, Salehpour S, Tohidi M, Saharkhiz N. Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship? Iranian journal of reproductive medicine. 2014;12(7):481.
Azziz R. Diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. The Journal of Clinical Endocrinology & Metabolism. 2006;91(3):781-5.
Kumar AN, Naidu JN, Satyanarayana U, Ramalingam K, Anitha M. Metabolic and endocrine characteristics of Indian women with polycystic ovary syndrome. International journal of fertility & sterility. 2016;10(1):22.
Zhao Y, Xu J, Zhu M, Lin J. Clinical features, reproductive endocrine and metabolic abnormalities of adolescent girls with polycystic ovary syndrome. Zhonghua yi xue za zhi. 2010;90(25):1729-34.
Yavasoglu I, Kucuk M, Coskun A, Guney E, Kadikoylu G, Bolaman Z. Polycystic ovary syndrome and prolactinoma association. Internal Medicine. 2009;48(8):611-3.
Abbasi M. Effects of Various contraceptive methods on Clinical and Metabolic Parameters. Arch Med Lab Sci. 2019;4(2).
Abbasi M. Investigation of the lipid profile in patients with subclinical hypothyroidism. Arch Med Lab Sci. 2017;3(4).
Zhao Y, Ruan X, Mueck AO. Clinical and laboratory indicators of polycystic ovary syndrome in Chinese Han nationality with different Rotterdam criteria-based phenotypes. Gynecological Endocrinology. 2016;32(2):151-6.
Sanyal D, Raychaudhuri M. Hypothyroidism and obesity: An intriguing link. Indian journal of endocrinology and metabolism. 2016;20(4):554.
Muscogiuri G, Sorice GP, Mezza T, Prioletta A, Lassandro AP, Pirronti T, et al. High‐normal tsh values in obesity: Is it insulin resistance or adipose tissue's guilt? Obesity. 2013;21(1):101-6.
Benetti-Pinto CL, Piccolo VRSB, Garmes HM, Juliato CRT. Subclinical hypothyroidism in young women with polycystic ovary syndrome: an analysis of clinical, hormonal, and metabolic parameters. Fertility and sterility. 2013;99(2):588-92.
- Abstract Viewed: 343 times
- pdf Downloaded: 216 times